戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n has been reported to be antiangiogenic and thrombogenic.
2 components, activates blood monocytes and is thrombogenic.
3 induced immunologically in these animals are thrombogenic.
4 e to the design of future VADs that are less thrombogenic.
5 ously adhered to the coated surface to block thrombogenic activation in the blood.
6  proteins retained their antigen binding and thrombogenic activities.
7 the TG assay for quantitative measurement of thrombogenic activity in immune globulin products.
8 nction of A2 as a force sensor in regulating thrombogenic activity in the vasculature.
9 sence of blood factors that reflect enhanced thrombogenic activity would be associated with an increa
10   Very large VWF multimers have the greatest thrombogenic activity, which is attenuated by cleavage i
11 on into the potential role of fibulin-1 as a thrombogenic agent.
12 significant antitumor effect, however, these thrombogenic agents had to occlude medium and large vess
13 he phospholipid binding site of beta2GPI are thrombogenic and activate endothelial cells.
14  expected to result in reduced inhibition of thrombogenic and anti-inflammatory activity on the endot
15 mmunization with beta2GPI, and these Abs are thrombogenic and cause pregnancy loss in mice.
16 propyltriethoxysilane (APTES) with both anti-thrombogenic and cell-adhesion properties.
17 lotted-tube stainless steel stents were more thrombogenic and created more extensive vascular injury
18 avorable health indices (higher atherogenic, thrombogenic and hypercholesterolemic saturated fatty ac
19 ), may function as a homeostatic response to thrombogenic and hypertensive stimuli and may have parti
20 whether drug-eluting coatings are inherently thrombogenic and if the response to these materials was
21 y analyzed the in vivo arteriovenous fistula thrombogenic and inflammatory macrophage response to sta
22                                              Thrombogenic and inflammatory mediators, such as thrombi
23 We suggest that blood-borne TF is inherently thrombogenic and may be involved in thrombus propagation
24 gh more durable than bioprostheses, are more thrombogenic and require lifelong anticoagulation.
25              The uremic milieu is profoundly thrombogenic and upregulates vSMC TF levels by increasin
26 he phospholipid-binding site of beta2GPI are thrombogenic and whether they activate endothelial cells
27 hrombi and thrombus-derived vasoconstrictor, thrombogenic, and inflammatory substances, however, redu
28                   These include thrombin and thrombogenic arterial wall substrates such as tissue fac
29           Fourth, increasing appreciation of thrombogenic atrial substrate and the common coexistence
30    Third, emerging evidence indicates that a thrombogenic atrial substrate can lead to atrial thrombo
31 involving the LAA has largely focused on its thrombogenic attribute and the utility of its exclusion
32                         We hypothesized that thrombogenic autoantibodies contribute to a procoagulant
33 olymorphism and metabolic, inflammatory, and thrombogenic blood markers.
34                                     Baseline thrombogenic blood tests included 6 hemostatic variables
35  a transmembrane receptor that initiates the thrombogenic cascade by assembly with the serine proteas
36 tissue factor (TFt), to locally initiate the thrombogenic cascade.
37 or vascular endothelial cells that initiates thrombogenic cascades, which may play a role in determin
38  mediates prostaglandin E(2) potentiation of thrombogenic coagonists including collagen and adenosine
39 sis was induced by x-ray-guided placement of thrombogenic-coated, MR-lucent stents (n=5).
40 , 1a and 1b spontaneously self-assemble into thrombogenic collagen-mimetic materials because of hydro
41 le magnesium scaffold was significantly less thrombogenic compared with the Absorb bioresorbable vasc
42                       Plaque rupture exposes thrombogenic components of the plaque, activating the cl
43 lformations will occur more frequently under thrombogenic conditions, such as those induced by thalid
44                           In addition to the thrombogenic content of a plaque, also the hemodynamic m
45  covered by a fibrous cap that separates the thrombogenic core from the blood.
46 evention in bypass systems, including highly thrombogenic CPB.
47 s, and provide a tool for the design of less thrombogenic devices.
48 rther evaluation as a possible treatment for thrombogenic disorders.
49                           Demonstration of a thrombogenic effect of murine anti-cardiolipin antibodie
50 or V, XI or XII deficiency; and in contrast, thrombogenic effects in patients with factor V-Leiden.
51             Treatment with IVIG inhibits the thrombogenic effects of aPL in vivo and reduces the leve
52 and severe tortuosity resulted in a strongly thrombogenic environment.
53 promotes inflammation, oxidative stress, and thrombogenic events.
54 sed diabetic and nondiabetic patients of the Thrombogenic Factors and Recurrent Coronary Events posti
55 es in blood lipids, insulin sensitivity, and thrombogenic factors.
56          Factors related to evolution of the thrombogenic fibrotic atrial cardiomyopathy support the
57  enabled the rapid immobilization of an anti-thrombogenic film in the presence of whole blood and per
58 tresses (statistically representing the VAD 'Thrombogenic Footprint').
59 eaves von Willebrand factor to smaller, less thrombogenic forms.
60 Willebrand factor multimers to generate less thrombogenic fragments.
61 or (VWF) in plasma to generate smaller, less thrombogenic fragments.
62 example, platelet deposition at the normally thrombogenic graft surface was substantially reduced rel
63 e also instrumental in the identification of thrombogenic impurities in immune globulin products, whi
64 travitreal injection of Ocriplasmin (Jetrea, Thrombogenics Inc, USA, Alcon/Novartis EU).
65 ent led to a decrease in the atherogenic and thrombogenic index values.
66 h led to low omega6/omega3, atherogenic, and thrombogenic index.
67                          The atherogenic and thrombogenic indexes (AI and TI, respectively) in soft m
68  supplementation reduced the atherogenic and thrombogenic indices of broiler chicken meat.
69 pid indices (PUFA/SFA ratio, atherogenic and thrombogenic indices) for both UAE-E:W extracts were sig
70  oha, and egusi soups had no atherogenic and thrombogenic indices.
71 eated and control mice, using a standardized thrombogenic injury procedure, and the area (size) of th
72                               A standardized thrombogenic injury was subsequently induced in the femo
73  Plaque ruptures that expose larger areas of thrombogenic intramural debris to flowing blood in areas
74      In a mouse model with a relatively mild thrombogenic lesion, TF-dependent FVIII activation sets
75 lly have thin fibrous caps overlying a large thrombogenic lipid core rich in lipid-laden macrophages.
76 optosis, probably promotes formation of this thrombogenic lipid pool whose size correlates with plaqu
77         Lipoprotein(a) is an atherogenic and thrombogenic lipoprotein, and has been implicated in the
78 e anticoagulant annexin A5 shield could be a thrombogenic mechanism in the aPL syndrome.
79 a deleterious effect of diet on CVD risk via thrombogenic mechanisms.
80 fects of AF-related remodeling on the atrial thrombogenic milieu by using radiofrequency ablation (RF
81  efforts were expanded to studies of the non-thrombogenic nature of heparinized biomaterials, prostag
82 atic pathway while attenuating the extrinsic thrombogenic pathway.
83 e proteases generated during inflammatory or thrombogenic pathways would elevate calcium concentratio
84 h, low-attenuating tissue layer that covered thrombogenic plaque components.
85 y which we have been able to investigate the thrombogenic potential of blood-borne TF.
86 mong standard mouse models, we evaluated the thrombogenic potential of platelets from healthy volunte
87                                          The thrombogenic potential of platelets subjected to mainstr
88 orphisms were suggested to contribute to the thrombogenic potential of S. sanguis.
89                                To assess the thrombogenic potential of the genetically engineered smo
90 po(a) may have a comparatively higher athero-thrombogenic potential than parent Lp(a).
91 ructural remodeling did not predict post-RFA thrombogenic potential.
92 r are critical players in the control of the thrombogenic process.
93 panded and novel role for L1 in vascular and thrombogenic processes.
94 bit TFPI, and consequently, may have a safer thrombogenic profile.
95 is the dominant contributor to its favorable thrombogenic profile.
96       Antiphospholipid antibodies (aPL) have thrombogenic properties in vivo, through their interacti
97 d polyclonal anticardiolipin antibodies have thrombogenic properties in vivo.
98  investigation to demonstrate the novel anti-thrombogenic properties of L-AME, when in solution and w
99 rkably, one of the monoclonal antibodies has thrombogenic properties when tested in an in vivo mouse
100 1 antibodies targeting this pathway revealed thrombogenic properties, which were subsequently shown t
101 aterial for osseous reconstruction given its thrombogenic properties.
102                         We assessed the anti-thrombogenic property of the coating using an in vitro b
103 ite with a tumor delivery agent, this potent thrombogenic protein in its truncated form (tTF) can be
104 sion of plasminogen activator inhibitor-1, a thrombogenic protein.
105 gy is plaque rupture with exposure of highly thrombogenic, red cell-rich necrotic core material.
106  Furthermore, a delayed and markedly reduced thrombogenic response was still evident in VWF(-/-), GPV
107  stress and inflammation, and inhibiting the thrombogenic response.
108 ture susceptibility to both inflammatory and thrombogenic responses caused by hypercholesterolemia.
109 phocytes, contribute to the inflammatory and thrombogenic responses, brain injury, and neurological d
110 eraction of collagen with VWF and subsequent thrombogenic responses.
111 ch as occlusion and to evaluate LAA flow for thrombogenic risk analysis.
112  oil supplementation on conventional CVD and thrombogenic risk markers were measured, along with the
113                                The potential thrombogenic risk of cyclooxygenase-2 inhibitors remains
114 hat although rapid atrial rates increase the thrombogenic risk, AF may further potentiate this risk.
115               The data are consistent with a thrombogenic role for S. sanguis in human disease, contr
116   There is increasing evidence regarding the thrombogenic role of neutrophils in essential thrombocyt
117 g a late-stage disease process, suggesting a thrombogenic role.
118 hirudin was assessed in vitro and in vivo on thrombogenic segments in chronically exteriorized femora
119 at doses that inhibited fibrin deposition on thrombogenic segments of arteriovenous shunts.
120 s forming on endovascular metallic stents or thrombogenic segments of vascular graft interposed in ex
121 tivity and most likely acts by pacifying the thrombogenic site of vascular injury.
122 could be a result of detachment of WBCs from thrombogenic sites, which may serve as a nidus for new c
123 ing in vascular shear flow and emigration at thrombogenic sites.
124 or expression may play a role in promoting a thrombogenic state in HITT.
125 e potential therapeutic role of TFPI in this thrombogenic state, mice were treated with intravascular
126  deposition in an animal model that combines thrombogenic stimulation with increased PAI-1 activity.
127 e molecular clock regulate the response to a thrombogenic stimulus in vivo.
128 mbin inhibitors is needed to "passivate" the thrombogenic substrate (disrupted arterial wall) and ach
129 aque rupture, smooth muscle cells may be the thrombogenic substrate.
130  (3) platelet and fibrin interactions with a thrombogenic surface, in a microfluidic model with circu
131 (2 dynes/cm2) to simulate venous flow over a thrombogenic surface.
132 rich thrombus by tethering the platelet to a thrombogenic surface.
133 of P2Y(12) in mediating platelet adhesion to thrombogenic surfaces (collagen, von Willebrand factor)
134                           Platelets bound to thrombogenic surfaces have been shown to support activat
135                     The pS-NO-BSA coating of thrombogenic surfaces reduces platelet adhesion and aggr
136 ased rate of platelet aggregate formation on thrombogenic surfaces, leading to accelerated thrombus g
137 tiating the adhesion of flowing platelets to thrombogenic surfaces.
138 elative residence time (RRT) associated with thrombogenic susceptibility was observed in the posterio
139        Increasing evidence suggests that the thrombogenic tendency in atrial fibrillation is related
140           Human lipid-rich plaques were more thrombogenic than less advanced atherosclerotic plaques.
141 strutted (162 mum) stents were 1.5-fold more thrombogenic than otherwise identical thin-strutted (81
142                                  We describe thrombogenic tissue factor (TF) on leukocyte-derived mic
143  triggers are known, our knowledge about the thrombogenic transcriptome changes in the microvessels i
144 c purpura (TTP), this is caused by a rise in thrombogenic ultra-large von Willebrand factor (VWF) mul
145  The proteolysis converts hyper-reactive and thrombogenic ULVWF into smaller and less adhesive plasma
146 iplatelet activity when coated on a normally thrombogenic vascular graft situated in an arteriovenous
147  1 repeats, member 13) proteolysis of highly thrombogenic von Willebrand factor (VWF) multimers may a

 
Page Top